Check out these blog posts from our Scientific Advisory Board members and other partners from the scientific community explaining the latest RET clinical trials.
RET Clinical Trial News and Information

Positive Results for Selpercatinib for Early Stage-RET Lung Cancer
Positive Results for Selpercatinib for Early Stage-RET Lung Cancer

Join the POISE study at Massachusetts General Hospital
Join the POISE study at Massachusetts General Hospital

Ellipses’ RET inhibitor EP0031 advances to Phase 2 clinical trials
Ellipses’ RET inhibitor EP0031 advances to Phase 2 clinical trials

Navigating The Lung Cancer Clinical Trial Enrollment Process
Navigating The Lung Cancer Clinical Trial Enrollment Process

Ethical Considerations in RET Lung Cancer Clinical Trials
Ethical Considerations in RET Lung Cancer Clinical Trials

From Safety to Approval: RET Lung Cancer Clinical Trial Phases
From Safety to Approval: RET Lung Cancer Clinical Trial Phases

Why Should You Participate in Lung Cancer Clinical Trials?
Why Should You Participate in Lung Cancer Clinical Trials?

The Harmonic™ Clinical Trial for Never Smokers
The Harmonic™ Clinical Trial for Never Smokers

New clinical trial testing amivantamab
New clinical trial testing amivantamab
Match to a clinical trial
